PD-Improved Dialysis Efficiency With Adapted APD
PD-IDEA
1 other identifier
observational
182
6 countries
50
Brief Summary
The aim of this study is to observe the effect of adapted APD (aAPD) on maintenance and/or improvement of the hydration status of more than 250 PD patients, and to observe the tolerability of the therapy over a long period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Longer than P75 for all trials
50 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 28, 2015
CompletedFirst Posted
Study publicly available on registry
June 12, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 6, 2020
July 1, 2020
5.3 years
April 28, 2015
August 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hydration status
Assessed via body composition measurements
Every three months during one year
Secondary Outcomes (4)
Residual renal function
Every three months during one year
Changes in prescription
Every three months during one year
Achievement of adequate solute removal
Every three months during one year
Therapy tolerability
Every three months during one year
Other Outcomes (1)
Change of therapy modality
Every three months during one year
Interventions
This is a purely non-interventional, observational study, where treatment decisions are completely guided by the discretion of the attending nephrologists
Eligibility Criteria
Patients with chronic kidney disease (CKD) being treated or starting renal replacement therapy with aAPD
You may qualify if:
- CKD patients with indication for renal replacement therapy
- Patient treated or to be treated with aAPD
- Fluid status regularly monitored with BCM
You may not qualify if:
- Patients who have any condition prohibiting the use of BCM like patients with major amputations (e.g. lower leg)
- Participation in an interventional study which could have an effect on the study objectives hydration status and dialysis adequacy (e.g. studies on PD solutions, studies on diuretics)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (50)
Faculty Hospital Brno-Bohunice
Brno, Czechia
Hospital Liberec
Liberec, Czechia
Regional Hospital in Mlada Boleslav
Mladá Boleslav, Czechia
Hospital Nove Mesto na Morave
Nové Město na Moravě, Czechia
Faculty Hospital Pilsen
Pilsen, Czechia
Faculty Hospital Karlovo namesti
Prague, Czechia
Faculty Hospital Strahov
Prague, Czechia
NC centre Vinohrady
Prague, Czechia
NC centre Sokolov
Sokolov, Czechia
Hospital Trebic
Třebíč, Czechia
Regional Hospital Viborg
Viborg, Denmark
Helsinki University Hospital
Helsinki, Finland
Kymenlaakso Central Hospital
Kotka, Finland
Regional Hospital Roskilde
Lappeenranta, Finland
Hospital Selayang
Batu Caves, Malaysia
Gleneagles Hospital Kuala Lumpur (GHKL)
Kuala Lumpur, Malaysia
Hospital Universiti Kebangsaan Malaysia (HUKM)
Kuala Lumpur, Malaysia
Hospital Serdang
Serdang, Malaysia
Hospital Seremban
Seremban, Malaysia
Complejo Hospitalario universitario de Albacete
Albacete, Spain
Fundación Hospital de Alcorcón
Alcorcón, Spain
Complejo Asistencial de Avila
Ávila, Spain
Fundacion Puigvert
Barcelona, Spain
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital de Basurto
Bilbao, Spain
Hospital General de Castellón
Castellon, Spain
Hospital Universitario di Girona Josep Trueta
Girona, Spain
Hospital General Virgen de las Nieves
Granada, Spain
Complejo hospitalario de Jaén
Jaén, Spain
Complejo Hospitalario San Millán-San Pedro De La Rioja
Logroño, Spain
Hospital Universitario Lucus Agusti
Lugo, Spain
Hospital Clínico San Carlos
Madrid, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Spain
Hospital Carlos Haya
Málaga, Spain
Complexo Hospitalario Universitario de Ourense (CHUO)
Ourense, Spain
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Spain
Hospital Universitatio Donostia
San Sebastián, Spain
Complejo Hospital Universitario de Santiago (CHUS)
Santiago de Compostela, Spain
Hospital Clínico de Valencia
Valencia, Spain
Hospital Peset
Valencia, Spain
Hospital Universitari i Politècnic La Fe
Valencia, Spain
Hospital Txagorritxu
Vitoria-Gasteiz, Spain
Danderyds Sjukhus AB
Danderyd, Sweden
Höglandssjukhuset Eksjö/Nässjö
Eksjö, Sweden
Kalmar Hospital
Kalmar, Sweden
Skåne University Hospital
Lund, Sweden
Länssjukhuset Sundsvall
Sundsvall, Sweden
Norra Älvsborgs Länssjukhus
Trollhättan, Sweden
Norrlands University Hopsital
Umeå, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michel Fischbach, Prof.
University Hospital Hautepierre
- STUDY DIRECTOR
Manel Vera, Dr.
Hospital Clinic i Provinvial de Barcelona
- STUDY DIRECTOR
Emilio Galli, Dr.
Ospedale "Treviglio-Caravaggio" di Treviglio
- STUDY DIRECTOR
Cecile Courivaud, Dr.
University Hospotal Besancon
- STUDY DIRECTOR
Virpi Rauta, Dr.
Helsinki Univerity Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2015
First Posted
June 12, 2015
Study Start
March 1, 2015
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
August 6, 2020
Record last verified: 2020-07